• Home
  • 9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901.

9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901.

Author List
Amin A, Halabi S, Gelmann EP, Stadler W, Vogelzang N, Small E
Publication
Urologic oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1439600
Publication Year
2004
PubMed ID
15464920
Publication Title
Amin A, Halabi S, Gelmann EP, Stadler W, Vogelzang N, Small E. 9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901. Urol Oncol. 2004 Sep-Oct; 22(5):398-403.